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the adipokines to their receptors. Interestingly, the downregulation
of adipokines was associated with the reduced expression of the
cartilage-speciﬁc transcription factor Sox9 and a strong increase
in the transcript level of collagen type 1. Chondrocytes recovered
a cartilage-like expression proﬁle of leptin and adiponectin when
cultured in alginate beads, but ceased expressing their receptors.
Conclusions: The modulation of chondrocyte phenotype induced
by experimental conditions affects the expression of adipokines
and their receptors. These experiment-dependent changes could
result in modiﬁcations of cell response to leptin or adiponectin, and
could therefore contribute to the discrepancies found in different
studies. These ﬁndings suggest also that adipokines may play an
essential role to prevent a phenotypic loss of chondrocyte function.
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AUTOPHAGY: A NEW TARGET IN THE HUMAN
OSTEOARTHRITIC CARTILAGE
M.C. de Andres, C. Ruiz-Romero, V. Calamia, J. Mateos,
F. Galdo, F.J. Blanco
Osteoarticular and Aging Res. Lab. Rheumatology Div.,
INIBIC-Complejo Hosp. Univ. A Coruña, A Coruña, Spain
Purpose: There is considerable evidence to suggest that pro-
grammed cell death (PCD) is not conﬁned to apoptosis and that
other mechanisms may also operate. One of these mechanisms
is the so-called “autophagic PCD”. Previously, some authors ob-
served that chondrocytes in OA cartilage demonstrated morpho-
logic changes that are characteristic features of apoptosis; how-
ever, we have observed the increase in autophagic levels in OA
cultured chondrocytes compared to normal cultured chondrocytes.
On the other hand, levels of microtubule-associated protein light
chain 3 (LC3), speciﬁcally LC3-II, is clearly correlated with the
number of autophagosomes.
The objective is to asses the levels of autophagy in normal and
OA human articular cartilage.
Methods: Normal and osteoarthritic (OA) human cartilages were
obtained from patients with joint replacement (femoral and knee
joint) and from autopsy cases (knee joint). To carry out studies
with cartilage, some pieces were frozen and subsequently pulver-
ized and other ones were cryopreserved until histologic studies
were done. The expression of the AuTophaGy-related (ATG) gen
LC-3 was assessed by means of western-blot and immunohisto-
chemistry using a speciﬁc policlonal antibody (Abcam, UK). Values
obtained by western-blot were normalized by means of α-tubuline
expression and the changes in this expression were measured us-
ing the ImageQuant (Version 5.2) program. On the other hand, 30
μg of cartilage extract was resolved using 2-DE; wide pH range
(nonlinear 3-10) was used for ﬁrst dimension and small format
polyacrylamide gels for the second dimension. The MS-compatible
silver staining was performed. The samples were analyzed using
the MALDI-TOF/TOF mass spectrometer 4700 Proteomics Ana-
lyzer (Applied Biosystems, Framingham, MA, USA).
Results: The study of LC-3 expression by means of western-
blot showed that OA human cartilage has higher expression of
LC3-II compared with normal cartilage (ratio >2). Densitometric
analysis was carried out by Image-Quant software. These ﬁndings
were corroborated with an immunohistochemistry study. On the
other hand, some autophagy-related proteins were identiﬁed by
means of MALDI-TOF/TOF mass spectrometer: lysozyme and
phospolipase; in both cases, the levels of these proteins were
signiﬁcantly higher in OA samples.
Conclusions: These results show the increase in autophagic
levels in OA human cartilage compared to normal human carti-
lage, conﬁrming the previous results with chondrocyte cultures.
The autophagy increase could contribute to the development and
progression of articular cartilage degeneration.
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HEME OXYGENASE-1 REGULATES INFLAMMATORY
MEDIATORS IN CARTILAGE ADJACENT TO SUBCHONDRAL
BONE FROM OSTEOARTHRITIC PATIENTS
V. Clérigues1, F. Gomar2, M. Alcaraz1, I. Guillén1,3
1Univ. of Valencia, Dept. Pharmacology, Burjasot, Spain; 2Univ. of
Valencia, Dept. Surgery, Valencia, Spain; 3Cardenal Herrera-CEU
Univ., Moncada, Spain
Purpose: Osteoarthritis (OA) produces articular degeneration
manifested by changes in the cartilage and subchondral bone.
Previously, we reported that heme oxygenase-1 (HO-1) is down-
regulated by catabolic factors in superﬁcial chondrocytes. The
function of these chondrocytes can be modulated by the cells
present in deeper zones including calciﬁed cartilage and subchon-
dral bone. The aim of the present work was to study the possible
protective effects of HO-1 against inﬂammatory mediators in this
area.
Methods: Osteochondral explants (including cartilage and sub-
chondral bone) of 3.5 mm of diameter were obtained from 10 pa-
tients with diagnosis of advanced OA undergoing total knee joint
replacement. Explants were maintained for 24h with DMEM/F12
and antibiotic and then stimulated with IL-1β (100 U/ml) and/or
the HO-1 inducer cobalt protoporphyrin IX (CoPP) during 72h.
Samples of culture medium were taken to measure prostaglandin
E2 (PGE2) by RIA and nitrite by a ﬂuorometric method. Tissue
explants were included in formalin (10%) for histological and im-
munohistological determinations. Cellular viability (evaluated by
the LDH method) and phenotype (collagen II expression) were
maintained throughout the culture period.
Results: We have shown by immunohistological analysis of ex-
plants that HO-1 and telomerase are predominantly expressed
in chondrocytes in the area next to subchondral bone. This ex-
pression was down-regulated in the presence of IL-1β. Besides,
this pro-inﬂammatory cytokine increased nitric oxide synthase-2
(NOS-2), cyclo-oxygenase-2 (COX-2) and high mobility group box
1 (HMGB1) expression in the same cells, as well as the levels
of nitrite and PGE2 in the culture medium. Induction of HO-1 by
CoPP reverted the effects of IL-1β on telomerase expression. In
addition, we observed a signiﬁcant decrease in NOS-2, COX-2
and HMGB1 expression by HO-1 up-regulation, accompanied by
reductions in the levels of corresponding metabolites.
Conclusions: In this work, we have shown a correlation be-
tween HO-1 and telomerase expression in chondrocytes adjacent
to subchondral bone, accompanied by inhibition of inﬂammatory
mediators. These results support the view that HO-1 may be a
potential target for cartilage regeneration and repair.
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REGULATION OF OSTEOARTHRITIC CHONDROCYTES BY
GROWTH AND DIFFERENTIATION FACTOR 5
P. Lavigne, J.-M. Brunet-Maheu, Q. Shi, M. Benderdour
Univ. of Montreal, Montreal, QC, Canada
Purpose: Genetic studies have identiﬁed osteoarthritis (OA) sus-
ceptibility genes that are present across different populations.
Interestingly, a majority of them are involved in developmental
processes and/or maintenance of cartilage and bone homeosta-
sis. Amongst these conﬁrmed susceptibility genes is growth and
differentiation factor (GDF) -5. Early in life, GDF-5 is an important
mediator of skeletal formation. However, little is known about the
physiologic role of this protein in adults and despite its genetic
association with OA, potential implication of GDF-5 protein in this
disease remains unknown. Therefore, the main objective of this
study is to assess the effect of rhGDF-5 on OA human and ca-
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nine chondrocytes. By looking at cartilage proteins expression and
degradative enzymes activity, we hope to identify GDF-5 action on
OA cartilage homeostasis.
Methods: Human OA chondrocytes were isolated from patients
undergoing knee replacement. Canine OA chondrocytes were
generated from the Nuki-Pond dog model. After in vitro expansion,
chondrocytes were co-incubated with increasing concentrations of
rhGDF-5. Expression of selected markers of cartilage metabolism
(aggrecans, type-I and -II collagen, ADAMST-4 and -5) was ana-
lyzed at the mRNA and protein levels using qRT-PCR and western
blot respectively. Aggrecans degradation products, which reﬂect
the activity of aggrecanases, were also analyzed by western blot
following GDF-5 stimulation.
Results: Similar responses were recorded in human and canine
chondrocytes. Stimulation of human and canine OA chondrocytes
with rhGDF-5 led to a dose-dependent increase of aggrecans and
type II/type I collagen ratio, with a concomitant decrease in both
ADAMTS-4 and ADAMTS-5 mRNA expression. A similar action
for rhGDF-5 was observed for aggrecans and ADAMTS-4 and
ADAMTS-5 at the protein level. Finally, aggrecans degradation
products were also signiﬁcantly decreased in OA chondrocytes
following rhGDF-5 stimulation.
Conclusions: Interestingly, the addition of rhGDF-5 had a dual
effect on OA chondrocytes, increasing markers of anabolic ac-
tivity and decreasing catabolic enzymes expression and activity.
These results suggest a key role for GDF-5 in maintaining carti-
lage homeostasis, an action that could be loss in OA. Because
GDF-5 concentrations are constant in normal and OA cartilage,
interference with GDF-5 signalling may occur in OA, an anomaly
that appears to be recovered by the addition of rhGDF-5. Further
in vivo studies will evaluate the potential of GDF-5 as a disease
modifying drug in OA.
234
INTERACTION BETWEEN 4-HYDROXYNONENAL-MODIFIED
EXTRACELLULAR MATRIX AND OSTEOARTHRITIC
CHONDROCYTES OR OSTEOBLASTS INDUCES CHANGES
IN CELL PHENOTYPE AND FUNCTION
R. El Bikai, Q. Shi, H. Fahmi, M. Benderdour
Univ. of Montreal, Montreal, QC, Canada
Purpose: Extracellular matrix (ECM) degradation and formation
are closely linked and tightly regulated in order to maintain carti-
lage and bone homeostasis. In cartilage and bone, accumulation
of 4-hydroxynonenal (HNE), a product of lipid peroxidation (LPO),
undergoes considerable alterations in ECM structure and thereby
rendering it more prone to mechanical damage. This study aimed
to demonstrate that interaction between HNE-modiﬁed extracel-
lular matrix and chondrocytes or osteoblasts induced changes in
cell morphology and function of these cells.
Methods: Plates culture were coated with 0.1 mg/well type II
collagen (Col II) and then modiﬁed by increasing concentrations
of HNE (0.1 to 2 mM). Chondrocytes or osteoblasts where then
incubated for 48 hrs in appropriate culture medium. Cell viability
was evaluated by MTT test. The protein expression of adhe-
sion molecules such as integrin αVβ3 and inter-cellular adhesion
molecule-1 (ICAM-1) is performed by Western blot. The level of
matrix metalloproteinase-13 (MMP-13), prostaglandin 2 (PGE2)
and osteocalcin (OC) was determined by ELISA using commercial
kits. Alkaline phosphatase (ALPase) activity was measured as the
release of p-nitrophenol hydrolysed from p-nitrophenyl phosphate.
Results: After 48 hrs of incubation, the modiﬁcation of Col II with 2
mM HNE induces shape change of chondrocytes and osteoblasts
from elongated phenotype to rounded phenotype with a 10% de-
crease in cell viability. At a functional level, the modiﬁcation of Col
II with 0.1-0.5 mM HNE enhanced the production of integrin αVβ3,
ICAM-1, MMP-13 and PGE2 in chondrocytes, and OC release and
ALPase activity in osteoblasts. In contrast, the modiﬁcation of Col
II with 1 and 2 mM HNE reduced their production in both cell
types.
Conclusions: Our results showed that interaction between HNE-
modiﬁed Col II and chondrocytes or osteoblasts induced changes
in cell phenotype of chondrocytes/osteoblasts and modulate the
expression of catabolic and inﬂammatory factors. As described
previously by our laboratory, we suggest that accumulation of
HNE/Col II adducts in OA cartilage and bone may play a critical
role in OA pathogenesis
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DIFFERENTIAL RESPONSE OF CARTILAGE EXPLANTS TO
CLINICALLY-RELEVANT LEVELS OF IL-1 AND
FIBRONECTIN FRAGMENTS
P. DiBenedetto, F. Chen, M. DiMicco, G. Matthews
Genzyme Corp., Framingham, MA
Purpose: In vitro, it is known that high doses of recombinant
interleukin-1 (IL-1) causes rapid and extensive cartilage degrada-
tion characterized by loss of proteoglycan from tissue to surround-
ing culture medium. However, IL-1 is only one of several potentially
catabolic factors detected in synovial ﬂuid from osteoarthritic (OA)
joints, and has been shown to be present at much lower con-
centrations than those typically employed in vitro. Our goal was
to expose cartilage explants to levels of IL-1 similar to those we
measured in OA synovial ﬂuid, assess the loss of sulfated GAG
from the tissue, and determine the effect of IL-1 blockade using
IL-1 receptor antagonist (IL-1ra).
Methods: Levels of IL-1 were determined in synovial ﬂuid collected
from OA patients. Bovine articular cartilage was harvested from
the patellofemoral groove of 3 adult animals, and prepared as
full-thickness discs 6 mm in diameter. These cartilage explants
were equilibrated for 48 hours in medium (DMEM with 50 μg/mL
gentamicin), then transferred to culture wells containing fresh
medium supplemented with IL-1 alpha ranging from 5000 ng/mL
(often used for in vitro degradation studies) to more clinically-
relevant levels (200, 20, 16, 8, 4, 2, 1, 0.5, and 0 ng/mL), based
on measured levels from above. To assess the contribution of other
potential catabolic factors, some cultures were also supplemented
with 30 kDa N-terminal fragment of ﬁbronectin (Fn-f) at reported
physiologic concentration (0.8 μM). The effect of IL-1 blockade
was assessed by preincubating some cartilage samples with 1.4
nM IL-1ra for 2 hours before addition of IL-1 or Fn-f. After 4
days, culture media were collected and assayed for sulfated GAG
content by DMMB, normalized to initial tissue wet weight. GAG
distribution was also visualized in cartilage discs by safranin-O
staining.
Results: Incubation of cartilage with IL-1 gave a dose-dependent
decrease in sGAG release between 5000 and 20 pg/mL. The
GAG content of the culture medium was not different from control
explants (no IL-1) for the range 0.5-20 pg/mL IL-1. Similarly, there
was no difference in safranin-O histology in this dose range.
Addition of IL-1ra to the culture medium completely inhibited this
loss. However, when Fn-f was included in the culture medium,
GAG release was increased, and the additional degradation was
not able to be inhibited by IL-1ra.
Conclusions: In later-stage OA patients, we and others have
detected IL-1 at very low levels. Incubation of cartilage with IL-1
at these concentrations did not induce GAG release over that of
untreated cartilage explants. However, at least one other catabolic
factor, Fn-f, induced degradation at a more clinically-relevant con-
centration. It may be that in advanced stages of OA, the contribu-
tion of IL-1 to degradation is not as pronounced as that of other
catabolic factors. While IL-1 may be more involved in earlier OA,
